AI-linked stocks surge as Sharon AI inks major Nvidia deal; New Oriental rises on Goldman upgrade, while Medline slides on fraud probe.

What happened: Sharon AI Holdings shares jumped 25% after announcing a six-year strategic compute collaboration with Nvidia to deploy 72 megawatts of new data center capacity in Australia, scaling up to 40,000 Grace Blackwell GB300 GPUs. New Oriental Education & Technology rose 3.8% following a Goldman Sachs upgrade to Buy with a 12-month price target of $65. Medline Inc slipped 2% after multiple law firms launched securities fraud investigations related to manufacturing practice violations cited in an FDA warning letter.

Why it matters: AI-linked stocks were among the strongest performers in premarket trading, supported by continued demand for data center infrastructure and computing capacity. The Sharon AI–Nvidia deal signals substantial new infrastructure investment aimed at supporting AI startups, enterprises, and university researchers. New Oriental's upgrade reflects Goldman Sachs' view of attractive valuation levels and potential upside relative to peers in China's internet and consumer sectors. Medline's drop stems from investigations into FDA-cited shortcomings in contamination investigations and cleaning procedures.

What to watch: The Sharon AI–Nvidia collaboration will deploy 72 megawatts of capacity with 40,000 Grace Blackwell GB300 GPUs in Australia over the six-year term. Broader U.S. stock futures advanced on Friday, with Dow futures rising 0.64%, S&P 500 futures gaining 0.5%, and Nasdaq 100 futures advancing 0.5%.